Leflunomide-related severe axonal neuropathy;Neuropathie axonale sévère et léflunomide

Revue Neurologique

Volumn 161, Issue 11, 2005, Pages 1106-1109

  Gabelle, A ^a   Antoine, J C ^b   Hillaire Buys, D ^c   Coudeyre, E ^c   Camu, W ^a  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b SERVICE DE NEUROLOGIE   (France)

^c LAPEYRONIE HOSPITAL   (France)

Author keywords

Aerse event; Axonal neuropathy; Leflunomide; Pharmacovigilance; Rheumatoid arthritis

Indexed keywords

LEFLUNOMIDE;

ADULT; AGED; ARTICLE; AXONAL POLYNEUROPATHY; CASE REPORT; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MOTOR SYSTEM; NERVE FIBER; NEUROPATHY; SENSORY SYSTEM;

EID: 29444442620     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(05)85178-1     Document Type: Article

References (8)

1. BAO C, CHEN S, Gu Y, LAO Z, NI L, Yu Q, XU J, LIU J, DING C. (2003). Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial. Chin Med J (Engl), 116: 1128-1234.
2. BONNEL RA, GRAHAM DJ. (2004). Peripheral neuropathy in patients treated with leflunomide. Clin Pharmacol Ther, 75: 580-585.
3. BURGER D, BEGUE-PASTOR N, BENAVENT S, GRUAZ L, KAUFMANN MT, CHICHEPORTICHE R, DAYER JM. (2003). The active metabolite of leflunomide, A771726, inhibits the production of prostaglandin E(2), matrix metalloproteinase 1, interleukin 6 in human fibroblast-like synoviocytes. Rheumatology, 42: 89-96.
4. CARULLI MT, DAVIES UM. (2002). Peripheral neuropathy: an unwanted effect of leflunomide? Rheumatology, 41: 952-953.
5. CHAN AT, BRADLOW A, MC NALLY J. (2003). Leflunomide induced vasculitis-a dose response relationship. Rheumatology, 42: 492-493.
6. ELKAYAM O, YARON I, SHIRAZI I, JUDOVITCH R, CASPI D, YARON M. (2003). Active leflunomide metabolite inhibits interleukin 1beta, tumor necrosis alpha, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures. Ann Rheum Dis, 62: 440-443.
7. LEGRAS A, BERGEMER-FOUQUET AM, JONVILLE-BERA AP. (2002). Fatal hepatitis with leflunomide and itraconazole. Am J Med, 113: 352-353.
8. SCHIFF MH, STRAND V, OED C, LOEW-FRIDRICH I. (2000). Leflunomide: efficacy and safety in clinical trails for the treatment of rheumatoid arthritis. Drugs Today, 36: 383-384.